HIV Market Forecast

Product Code DAT15694
Publication Date July 2010
Publisher Datamonitor
Product Type Interactive Model
Pages 0
ISBN Number not applicable
Change currency
PDF £9,615.00 €11,579 $15,204 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

HIV Market Forecast

In 2009, HIV antiretroviral sales across the seven major markets totalled $11.8 billion, growing at a CAGR of 10.8% between 2005 and 2009. While new cross-class fixed dose combinations will ensure market growth until 2015, Datamonitor expects major patent expiries and rising pressure to reduce healthcare costs to trigger a decline in HIV sales in the second half of the forecast period until 2019.

Reasons to Purchase

  • Understand the changing market dynamics of HIV drugs, success factors for leading brands and the commercial potential of late stage pipeline products.
  • Assess the impact of events such as patent expiries and new product launches on individual brands and the overall HIV antiretroviral market.
  • Obtain full country, class and product-specific forecasts of currently marketed and pipeline antiretrovirals from 2010 to 2019.

Contents

  • Not Available